Literature DB >> 12628455

Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review.

Jürgen Wess1, Alokesh Duttaroy, Jesus Gomeza, Weilie Zhang, Masahisa Yamada, Christian C Felder, Nadia Bernardini, Peter W Reeh.   

Abstract

To gain new insight into the physiological and pathophysiological roles of the muscarinic cholinergic system, we generated mutant mouse strains deficient in each of the five muscarinic acetylcholine receptor subtypes (M(1)-M(5)). In this chapter, we review a set of recent studies dealing with the identification of the muscarinic receptor subtypes mediating muscarinic agonist-dependent analgesic effects by central and peripheral mechanisms. Most of these studies were carried out with mutant mouse strains lacking M(2) or/and M(4) muscarinic receptors. It is well known that administration of centrally active muscarinic agonists induces pronounced analgesic effects. To identify the muscarinic receptors mediating this activity, wild-type and muscarinic receptor mutant mice were injected with the non-subtype-selective muscarinic agonist, oxotremorine (s.c., i.t., and i.c.v.), and analgesic effects were assessed in the tail-flick and hot-plate tests. These studies showed that M(2) receptors play a key role in mediating the analgesic effects of oxotremorine, both at the spinal and supraspinal level. However, studies with M(2)/M(4) receptor double KO mice indicated that M(4) receptors also contribute to this activity. Recent evidence suggests that activation of muscarinic receptors located in the skin can reduce the sensitivity of peripheral nociceptors. Electrophysiological and neurochemical studies with skin preparations from muscarinic receptor mutant mice indicated that muscarine-induced peripheral antinociception is mediated by M(2) receptors. Since acetylcholine is synthesized and released by different cell types of the skin, it is possible that non-neuronally released acetylcholine plays a role in modulating peripheral nociception. Our results highlight the usefulness of muscarinic receptor mutant mice to shed light on the functional roles of acetylcholine released from both neuronal and non-neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628455     DOI: 10.1016/s0024-3205(03)00082-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  27 in total

1.  Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  Kelly A Carrigan; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

2.  Muscarinic acetylcholine receptor subtype expression in avian vestibular hair cells, nerve terminals and ganglion cells.

Authors:  G Q Li; G A Kevetter; R B Leonard; D J Prusak; T G Wood; M J Correia
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

Review 3.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

4.  Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.

Authors:  Brian Dean; Shaun Hopper; P Jeffrey Conn; Elizabeth Scarr
Journal:  Neuropsychopharmacology       Date:  2015-10-29       Impact factor: 7.853

Review 5.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

6.  Cholinergic modulation during acquisition of olfactory fear conditioning alters learning and stimulus generalization in mice.

Authors:  Eloisa Pavesi; Allison Gooch; Elizabeth Lee; Max L Fletcher
Journal:  Learn Mem       Date:  2012-12-14       Impact factor: 2.460

7.  Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.

Authors:  You-Qing Cai; Shao-Rui Chen; Hee-Dong Han; Anil K Sood; Gabriel Lopez-Berestein; Hui-Lin Pan
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

Review 8.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

9.  Quercetin ameliorates paclitaxel-induced neuropathic pain by stabilizing mast cells, and subsequently blocking PKCε-dependent activation of TRPV1.

Authors:  Wei Gao; Yan Zan; Zai-Jie Jim Wang; Xiao-Yu Hu; Fang Huang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

Review 10.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.